Follow
Javier Molina
Javier Molina
Hospital Universitario Ramón y Cajal
Verified email at salud.madrid.org
Title
Cited by
Cited by
Year
Targeting HIF-2 α in clear cell renal cell carcinoma: A promising therapeutic strategy
O Martínez-Sáez, PG Borau, T Alonso-Gordoa, J Molina-Cerrillo, ...
Critical reviews in oncology/hematology 111, 117-123, 2017
1202017
Bruton’s tyrosine kinase (BTK) as a promising target in solid tumors
J Molina-Cerrillo, T Alonso-Gordoa, P Gajate, E Grande
Cancer Treatment Reviews 58, 41-50, 2017
1182017
Complete remissions following immunotherapy or immuno-oncology combinations in cancer patients: the MOUSEION-03 meta-analysis
M Santoni, A Rizzo, J Kucharz, V Mollica, M Rosellini, A Marchetti, ...
Cancer Immunology, Immunotherapy 72 (6), 1365-1379, 2023
1162023
BRAF mutated colorectal cancer: New treatment approaches
J Molina-Cerrillo, M San Román, J Pozas, T Alonso-Gordoa, M Pozas, ...
Cancers 12 (6), 1571, 2020
662020
Tyrosine kinase receptors in oncology
J Esteban-Villarrubia, JJ Soto-Castillo, J Pozas, M San Román-Gil, ...
International journal of molecular sciences 21 (22), 8529, 2020
612020
Targeting tyrosine kinases in renal cell carcinoma:“new bullets against old guys”
T Alonso-Gordoa, ML García-Bermejo, E Grande, P Garrido, A Carrato, ...
International journal of molecular sciences 20 (8), 1901, 2019
492019
New oncologic emergencies: What is there to know about inmunotherapy and its potential side effects?
A Barquín-García, J Molina-Cerrillo, P Garrido, D Garcia-Palos, A Carrato, ...
European Journal of Internal Medicine 66, 1-8, 2019
352019
Molecular mechanisms of resistance to immunotherapy and antiangiogenic treatments in clear cell renal cell carcinoma
PÁ Ballesteros, J Chamorro, MS Román-Gil, J Pozas, ...
Cancers 13 (23), 5981, 2021
322021
The PALBONET Trial: A phase II study of palbociclib in metastatic grade 1 and 2 pancreatic neuroendocrine tumors (GETNE‐1407)
E Grande, A Teulé, T Alonso‐Gordoa, P Jiménez‐Fonseca, M Benavent, ...
The Oncologist 25 (9), 745-e1265, 2020
292020
Inhibition of peripheral synthesis of serotonin as a new target in neuroendocrine tumors
J Molina-Cerrillo, T Alonso-Gordoa, O Martínez-Sáez, E Grande
The Oncologist 21 (6), 701-707, 2016
292016
Novel molecular characterization of colorectal primary tumors based on miRNAs
E Conde, A Pascual, D Prieto-Cuadra, VF Laza, J Molina-Cerrillo, ...
Cancers 11 (3), 346, 2019
282019
Protocol for presurgical and anesthetic management of pheochromocytomas and sympathetic paragangliomas: a multidisciplinary approach
M Araujo-Castro, E Pascual-Corrales, L Nattero Chavez, A Martínez Lorca, ...
Journal of Endocrinological Investigation 44, 2545-2555, 2021
222021
Targeting angiogenesis in pancreatic neuroendocrine tumors: resistance mechanisms
J Pozas, M San Román, T Alonso-Gordoa, M Pozas, L Caracuel, ...
International journal of molecular sciences 20 (19), 4949, 2019
222019
Cabozantinib in patients with advanced renal cell carcinoma primary refractory to first-line immunocombinations or tyrosine kinase inhibitors
M Santoni, F Massari, S Bracarda, E Grande, MR Matrana, M Rizzo, ...
European Urology Focus 8 (6), 1696-1702, 2022
192022
Sunitinib and Evofosfamide (TH-302) in Systemic Treatment-Naïve Patients with Grade 1/2 Metastatic Pancreatic Neuroendocrine Tumors: The GETNE-1408 Trial
E Grande, C Rodriguez-Antona, C López, T Alonso-Gordoa, M Benavent, ...
The Oncologist 26 (11), 941-949, 2021
172021
Immunotherapy in adrenocortical carcinoma: predictors of response, efficacy, safety, and mechanisms of resistance
M Araujo-Castro, E Pascual-Corrales, J Molina-Cerrillo, T Alonso-Gordoa
Biomedicines 9 (3), 304, 2021
172021
Resistance to RET targeted therapy in Thyroid Cancer: Molecular basis and overcoming strategies
M San Roman-Gil, J Pozas, D Rosero-Rodriguez, J Chamorro-Perez, ...
Cancer treatment reviews 105, 102372, 2022
152022
Prognostic and predictive role of the PI3K–AKT–mTOR pathway in neuroendocrine neoplasms
P Gajate, T Alonso-Gordoa, O Martínez-Sáez, J Molina-Cerrillo, E Grande
Clinical and Translational Oncology 20, 561-569, 2018
142018
Primary sarcomatoid tumor of the bladder: a different entity but the same approach?
J Molina-Cerrillo, O Martínez-Sáez, T Alonso-Gordoa, P Tirado-Zambrano, ...
Clinical Genitourinary Cancer 13 (6), 493-498, 2015
122015
Bronchial carcinoids: from molecular background to treatment approach
M Araujo-Castro, E Pascual-Corrales, J Molina-Cerrillo, N Moreno Mata, ...
Cancers 14 (3), 520, 2022
112022
The system can't perform the operation now. Try again later.
Articles 1–20